Uncategorized

SystImmune, Inc has announced that it will present data from seven preclinical programs in poster presentations at the American Association of Cancer Research meeting, which will be held in Orlando, FL, from April 14th to 19th, 2023.

Zura Bio Limited, a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorders, announced the appointment of Michael D. Howell, Ph.D., to the role of Chief Scientific Officer and Head of Translational Science.

Alvotech announced that the U.S. Food and Drug Administration has issued a complete response letter for Alvotech’s Biologics License Application for AVT02, a high-concentration biosimilar candidate for Humira®.

Nicox SA, an international ophthalmology company, announced that its exclusive Chinese partner, Ocumension Therapeutics, has submitted a New Drug Application for approval to commercialize ZERVIATE®, 0.24%, in China, for ocular itching associated with allergic conjunctivitis.

Teva Pharmaceutical Industries Ltd. announced that the U.S. Food and Drug Administration has issued a complete response letter to its partner Alvotech for the Biologics License Application for AVT02, a high-concentration biosimilar candidate for Humira®.

RELIEF THERAPEUTICS Holding SA reported its financial results for the full-year ended December 31, 2022 and provided a corporate update.

Hansa Biopharma AB will publish its interim report for January-March 2023 at 8:00 CET on April 20, 2023.

JEOL Ltd. announces launch of a new Cryogen Reclamation System for Nuclear Magnetic Resonance on April 14, 2023.

The ratings agency said healthcare’s vulnerable state makes it “target rich,” which could bring service disruptions and personal data disclosures.

The order is the latest twist in an escalating legal battle over access to mifepristone, a fight that is headed to the Supreme Court.